Tim Kutzkey, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 22,631 shares at $0.62 ($16K) on 2023-11-16, disclosed to the SEC on 2023-11-17.
Open-market purchase of $16k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 16,791 | $12K | 76.7% |
| 2 | $0.62 | 5,840 | $4K | 23.3% |
| Total | $0.69 avg | 22,631 | $16K | 100% |
| Filing → |
| SRZN | BUY | 2026-01-08 | $300K | — | Filing → |
| SRZN | BUY | 2025-12-08 | $1.3M | — | Filing → |
| SRZN | BUY | 2025-12-02 | $8.0M | — | Filing → |